Mercyone North Iowa Medical Center | |
1000 Fourth Street Sw, Mason City, Iowa 50401 | |
(641) 428-7000 | |
Name | Mercyone North Iowa Medical Center |
---|---|
Type | Acute Care Hospital |
Location | 1000 Fourth Street Sw, Mason City, Iowa |
Ownership | Voluntary non-profit - Private |
Emergency Services | Yes |
Medicare ID (CCN) | 160064 |
NPI Number | 1467537886 |
Organization Name | MERCY HEALTH SERVICES-IOWA CORP |
Doing Business As | MERCY MEDICAL CENTER-NORTH IOWA |
Address | 1000 4th St Sw, Mason City, IA 50401 |
Hospital Type | General Acute Care Hospital |
Phone Number | 641-428-7000 |
News Archive
The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific and sensitive COVID-19 diagnostic that would integrate the Institute's eRapid technology with the company's proprietary transistor sensor technology to enable simultaneous electrochemical sensing of multiple biomarkers related to SARS-CoV-2 infection in point-of-care COVID-19 diagnostic applications.
Professor Varinder Aggarwal is no ordinary builder. He and his team in the School of Chemistry have just discovered a new technique that could hasten the development of new drugs for today's incurable diseases – by building complex organic molecules.
The American Hospital Association (AHA) today announced it has exclusively endorsed rL Solutions Risk MonitorPro® for healthcare incident management. Risk MonitorPro is a web-based incident and adverse event management system that allows users to easily submit, refine, analyze and communicate critical incident information.
The Seattle Times examines how the Bill & Melinda Gates Foundation's goal to eradicate malaria is shaping aspects of global research.
InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced enrollment of the first patient in its Phase 2 clinical trial, CANARY (Coronary Assessment by Near-infrared (NIR) of Atherosclerotic Rupture-prone Yellow).
› Verified 8 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific and sensitive COVID-19 diagnostic that would integrate the Institute's eRapid technology with the company's proprietary transistor sensor technology to enable simultaneous electrochemical sensing of multiple biomarkers related to SARS-CoV-2 infection in point-of-care COVID-19 diagnostic applications.
Professor Varinder Aggarwal is no ordinary builder. He and his team in the School of Chemistry have just discovered a new technique that could hasten the development of new drugs for today's incurable diseases – by building complex organic molecules.
The American Hospital Association (AHA) today announced it has exclusively endorsed rL Solutions Risk MonitorPro® for healthcare incident management. Risk MonitorPro is a web-based incident and adverse event management system that allows users to easily submit, refine, analyze and communicate critical incident information.
The Seattle Times examines how the Bill & Melinda Gates Foundation's goal to eradicate malaria is shaping aspects of global research.
InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced enrollment of the first patient in its Phase 2 clinical trial, CANARY (Coronary Assessment by Near-infrared (NIR) of Atherosclerotic Rupture-prone Yellow).
› Verified 8 days ago
Mercyone North Iowa Medical Center Acute Care Hospital Location: 1000 Fourth Street Sw, Mason City, Iowa 50401 Phone: (641) 428-7000 |